Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
OncoSil Medical Ltd ( (AU:OSL) ) has shared an update.
OncoSil Medical Ltd has announced the application for the quotation of new securities on the Australian Securities Exchange (ASX). The company is set to quote 41,667 options expiring on July 31, 2027, as part of its strategic financial maneuvers. This move is likely to impact the company’s financial positioning and provide additional resources to support its ongoing projects and market expansion efforts.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of innovative medical devices. The company’s primary product is a targeted radioactive implant designed to treat pancreatic and liver cancer, aiming to improve patient outcomes in these challenging areas.
Average Trading Volume: 45,789
Technical Sentiment Signal: Sell
Current Market Cap: A$21.27M
Find detailed analytics on OSL stock on TipRanks’ Stock Analysis page.